Zobrazeno 1 - 10 of 34 pro vyhledávání: '"M G, Franzosi"'
1
Effects of long-term, moderate-intensity oral anticoagulation in addition to aspirin in unstable angina
Autor: H. Rupprecht, B. Cracknell, H. Hernandez, Shamir R. Mehta, G. Wyse, M. A. Ramos-Corrales, M. G. Franzosi, J. Mackay, C. Christmas, C. Rihal, Andrzej Budaj, Michael Gent, C. Cuvay, J. Varigos, W. Wasek, K. Nair, David A. Halon, J. Wittes, B. Sussex, Akbar Panju, J Pogue, J. Willerson, Jeffrey I. Weitz, L. Ceremuzynski, Andre Lamy, B. S. Lewis, Salim Yusuf, F. Mazur, L. Piegas, C. Sigouin, G. Tognoni, A Avezum, M. Galli, P. Commerford, M. Anderson, I. Stoica, R. Gorlin, L. Tomic, J. Cairns, F. Mauri, Y. K. Chan, I. Holadyk-Gris, J. Brown, Bongani M. Mayosi, P. Auger, R. Diaz, M. Micks, T. Wittlinger, M. Johnston, H. Marsh, P. Theroux, M. Flather, Jeffery L. Anderson, F. Cherian, A. Maggioni, L. Cronin, M. Kyriakidis, J. F. Marquis, S. Kotlan, Madhu K. Natarajan, Jack Hirsh, M. Sloan, C. Joyner, N. Karatzasy, K. Fox, S. Seitz, S. Smith, E. Sitkei, L. Robinson, Amiram Gafni, Sonia S. Anand, Dereck L. Hunt, M. Keltai, J. Tucker, E. Paolasso, J. Lindeman
Publikováno v: Journal of the American College of Cardiology. 37:475-484
OBJECTIVESWe sought to evaluate whether oral anticoagulant (AC) therapy given for five months was superior to standard (control) therapy in patients with unstable angina receiving aspirin.BACKGROUNDThe long-term risk of myocardial infarction (MI) or
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::03b260d1b6c9fef7b4170672fc1fdac1
https://doi.org/10.1016/s0735-1097(00)01118-9
Zobrazit plný text záznamu
2
The Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) trial programme. Rationale, design and baseline characteristics including a meta-analysis of the effects of thienopyridines in vascular disease
Autor: M. Keltai, Michael Gent, A Sosa Liprandi, T. Wittlinger, Andrzej Budaj, Piotr Szymański, A Avezum, M. Galli, H. De Raedt, M. Sotty, E. G. Hasbani, J. Bouthier, S. Chrolavicius, P. J. Commerford, B. J. Gersh, N. Awan, Bongani M. Mayosi, M. Den Hartoog, F. Zhao, P. Widimsky, S. Kopecky, F. Mauri, P. Commerford, Christophe Gaudin, A. Pipilis, J. Norris, J Pogue, D. C G Basart, J. Wittes, Y. K. Chan, J. Cairns, K Hall, J. Varigos, A. Maggioni, K. Fox, A. A. Fernandez, M. Nieminen, I. Copland, T. Mocceti, J. Renkin, Akbar Panju, S. Ounpuu, P. Montague, R. J. Peters, V. Yacyshyn, J. J. Fuselli, E. Sitkei, H. Rupprecht, J. O. Bono, M. Bertrand, J. Keys, M. Flather, Sonia S. Anand, Dereck L. Hunt, T. Ryan, J. F. Marquis, Madhu K. Natarajan, Jack Hirsh, R. A. Ahuad Guerrero, W. Grossman, Robert G. Hart, P. Auger, T. Hess, C. Rihal, J. Morais, R. Diaz, Matthew J. McQueen, W. Wasek, B. Cracknell, C. Joyner, A. J. Gambarte, J. Garcia-Guerrero, B. Morris, L. Ceremuzynski, G. Tognoni, N. Karatzas, K. Malmberg, A. Caccavo, L. Piegas, C. Wright, Catherine Demers, N. Khurmi, David A. Halon, G. Allende, Vicent Valentin, E. Paolasso, R. Peters, M. A. Ramos-Corrales, M. G. Franzosi, J. Col, L. Ryden, Shamir R. Mehta, G. Wyse, B. S. Lewis, John W. Eikelboom, M. Blumenthal, Salim Yusuf
Publikováno v: European Heart Journal. 21:2033-2041
Background Other than aspirin, there are few oral antithrombotic treatments with proven efficacy in patients with acute coronary syndrome. In this report, we present the rationale, design and baseline characteristics of the Clopidogrel in Unstable an
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c90fa1449354b46583dfc7753e941ea
https://doi.org/10.1053/euhj.2000.2474
Zobrazit plný text záznamu
3
Circulating cardiovascular biomarkers in recurrent atrial fibrillation: data from the GISSI-atrial fibrillation trial
Autor: R, Latini, S, Masson, S, Pirelli, S, Barlera, G, Pulitano, E, Carbonieri, M, Gulizia, T, Vago, C, Favero, D, Zdunek, J, Struck, L, Staszewsky, A P, Maggioni, M G, Franzosi, M, Disertori
Publikováno v: Journal of internal medicine. 269(2)
we evaluated the prognostic role of circulating cardiovascular biomarkers in patients with a history of recent atrial fibrillation (AF).predicting long-term maintenance of sinus rhythm in patients with AF is difficult.plasma concentrations of three s
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::492f05639bc60a3781b14180d21010f5
https://pubmed.ncbi.nlm.nih.gov/20964739
Zobrazit plný text záznamu
4
Rationale and design of ACTIVE: the atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events
Autor: Susan Chrolavicius, Campbell D. Joyner, Ernesto Paolasso, William S. Weintraub, Nicholas Karatzas, G Frangin, S H Hohnloser, C Proste, Karl Swedberg, J-Y Le Heuzey, Ron J.G. Peters, Fernando Lanas, Heather M. Arthur, W. Van Mieghem, Active W Investigators, Basil S. Lewis, A Budaj, M-G Franzosi, Matyas Keltai, João Morais, Carlos A. Morillo, Gregory C. Flaker, Mel Blumenthal, Patrick J. Commerford, David A. Halon, Mario Talajic, Petr Jansky, Christopher B. Granger, John Varigos, Samuel Z. Goldhaber, M Bethala-Sithya, Marcus Flather, Eva Sitkei, C P Lau, Christophe Gaudin, Rafael Diaz, T Pipillis, L Ceremuzynski, John Camm, Antonio G. Hermosillo, M Pfisterer, A Avezum, Ali Oto, Robert G. Hart, David M. Hunt, Leopoldo S. Piegas, Stuart J. Connolly, David Synhorst, R. De Caterina, Vicent Valentin, Inderjit Anand, Keith A.A. Fox, V Trégou, Marc A. Pfeffer, Sergey P. Golitsyn, Salim Yusuf
Publikováno v: American heart journal, 151(6), 1187-1193. Mosby Inc.
Background Atrial fibrillation (AF) is the most frequently occurring cardiac arrhythmia with often serious clinical consequences. Many patients have contraindications to anticoagulation, and it is often underused in clinical practice. The addition of
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e50762bdd2f5b7ace5a3514c9283e5c0
https://pubmed.ncbi.nlm.nih.gov/16781218
Zobrazit plný text záznamu
5
Aspirin does not interact with ACE inhibitors when both are given early after acute myocardial infarction: results of the GISSI-3 Trial
Autor: R, Latini, E, Santoro, S, Masson, L, Tavazzi, A P, Maggioni, M G, Franzosi, S, Barlera, L, Calvillo, M, Salio, L, Staszewsky, V, Labarta, G, Tognoni
Publikováno v: Heart disease (Hagerstown, Md.). 2(3)
Aspirin (ASA) and angiotensin-converting enzyme inhibitor (ACEi) therapy reduce mortality when administered early after the onset of myocardial infarction. ASA can antagonize some effects of ACEi therapy by inhibiting the synthesis of vasodilating pr
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::95d0c219bccba277ef38dd96dda0b67f
https://pubmed.ncbi.nlm.nih.gov/11794142
Zobrazit plný text záznamu
6
[Susceptibility gene to infarct: a review of the literature]
Autor: B D, Chiodini, S, Barlera, M G, Franzosi, G, Tognoni
Publikováno v: Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology. 2(9)
The investigation on the susceptibility genes of myocardial infarction has initiated substantially in the last 20 years. Most efforts have been mainly addressed to identify and evaluate genes involved in those systems already suspected to be implicat
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::64d942a8e50f08281694c652e5601f99
https://pubmed.ncbi.nlm.nih.gov/11675831
Zobrazit plný text záznamu
8
[PROCARDIS: A current approach to the study of the genetics of myocardial infarct]
Autor: S, Barlera, B D, Chiodini, M G, Franzosi, G, Tognoni
Publikováno v: Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology. 2(9)
Coronary artery disease is a complex and multifactorial pathology. Although the environmental component of coronary artery disease has been thoroughly investigated and is hence well known, knowledge about the genetic factors implicated in this diseas
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::bc69efa5332cff4ae3edcfe29f2a8584
https://pubmed.ncbi.nlm.nih.gov/11675837
Zobrazit plný text záznamu
10
Internet for clinical trials: past, present, and future
Autor: E, Santoro, E, Nicolis, M G, Franzosi, G, Tognoni
Publikováno v: Controlled clinical trials. 20(2)
The Internet and World Wide Web have recently been introduced into the management of some aspects of large-scale clinical trials such as remote randomization and data entry and the distribution of information on trial progress. Electronic mail and we
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::acc1f26a2645928a788e4b91935fe8e3
https://pubmed.ncbi.nlm.nih.gov/10227418
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje